Isomorphic Labs: Hassabis‘ Pharma AI Set for 5 Billion Dollar Mega-Round Without a Single Drug Tested in Humans

Isomorphic Labs is in early talks to raise approximately 5 billion dollars at a valuation of around 50 billion dollars, according to Bloomberg reports. The AI drug discovery company, spun out of Google DeepMind and led by Demis Hassabis, has yet to test a single drug candidate of its own in humans. If completed, the new funding would bring Isomorphic's total capital raised to roughly 7.7 billion dollars in about 18 months, driven largely by high-profile pharma partnerships with companies like Eli Lilly and Novartis. Open article →